This report includes all four volumes of Kalorama's 2nd edition of its Drug Delivery Markets series, covering all major types, including:
Oral Delivery
Implantable/Injectable
Pulmonary
Transdermal/Transmucosal
Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. While oral delivery remains the most popular and cost-effective methods, implantable and injectable and pulmonary methods are options for fast distribution and stronger dosage. Transdermal patches and new electric transfers allow painless entry for medicines that cannot be administered orally.
Kalorama's Drug Delivery Markets series provides exhaustive coverage of four key areas of drug delivery.

As part of Kalorama's trusted information-gathering process, over 70 industry executives in the drug delivery area were interviewed, along with through research of public information, medical journals and company reports. Interviews provide the basis of forecasts.

Drug Delivery Markets, Vol I: Oral Delivery
Chapter one: Executive Summary


Market Drivers
Market Size and Growth
Total Oral Drug Delivery Market
Oral Drug Delivery Technology Only Market


Competitive and Market Analysis
Chapter two: Introduction and Overview


Scope of the Report
Methodology
History of Oral Drug Delivery
Phases of Drug Action
Barriers to Oral Drug Delivery
Controlled-Release/Sustained-Release
Delayed Release and Modified Release
Fast Dissolving
Taste-Masked
Pulsatile Release
Microemulsion and Others
Chapter three: Key Trends and Demographics


The Elderly
Regulatory Environment
Patent Protection and Extension
Earlier Involvement
Consolidation
Proprietary Product Development
Implications for Generic and Over-the-Counter Products
Pharmaceutical Formulation
Chapter four: New Developments


Macromolecule Delivery
Delivery of Hydrophobic Drugs
Other Delivery Solutions
Chapter five: Market Size and Growth


The Total Oral Drug Delivery Market
Oral Delivery Technology Only Market
Chapter six: Competitive Analysis


Competitive Landscape
Chapter seven: Company Profiles


ALZA Corporation
Andrx Pharmaceuticals
Biovail Corporation
Cardinal Health
Elan Corporation, plc
Emisphere Technologies, Inc.
KV Pharmaceutical
Labopharm, Inc.
Penwest Pharmaceutical Company
Purdue/MundiPharma/Napp Group
SkyePharma PLC
Chapter eight: Companies in Brief


Alkermes, Inc.
Astellas
BioProgress Technologies International, Inc.
CIMA Labs, Inc. Division of Cephalon
DepoMed, Inc.
Endorex, Inc.
Eurand, Inc.
Kos Pharmaceuticals, Inc.
Lipocine, Inc.
Appendix: Company Directory




List of Exhibits



Chapter one: Executive Summary


Chapter two: Introduction and Overview
Table 2-1: Selected Types of Oral Solid Preparations
Table 2-2: Sequence of Drug Action
Chapter three: Key Trends and Demographics


Table 3-1: World Population by Age Group 2002-2010
Figure 3-1: World Population by Age Group 2002-2010
Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter four: New Developments
Chapter five: Market Size and Growth


Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010
Chapter six: Competitive Analysis


Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)
Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems

Chapter one: Executive Summary


Market Drivers
Market Size and Growth
Total Injectable/Implantable Drug Delivery Market
The Injectable/Implantable Drug Delivery Only Market


Competitor and Market Analysis
Chapter two: Introduction


Scope and Methodology
Reasons for Injectable/Implantable Drug Delivery Systems
History of Injectable/Implantable Drug Delivery
Phases of Drug Action
Needle-Free Drug Delivery
Major Applications
Safety Concerns
Products


Implantable Drug Delivery
Mechanisms
Applications
Products


Sustained-Release Drug Delivery
Products


Targeted Injection Drug Delivery
Products
Chapter three: Trends and Developments


Drivers of the Injectable/Implantable Drug Delivery Market
Biologics
Cancer


Pen injectors
Proprietary Product Development
Delivery Systems Placement Trends
Therapeutic Trends
Incorporation of Technology
Nanotechnology
Drug Delivery Development
Microsphere Technology
Targeted Technology
MicroChip Technology
NanoParticles
Protein-Coated Microcrystal Technology
Needle-Free Delivery Development
Selected Products in Development
Chapter four: Market Size and Growth


The Total Injectable/Implantable Drug Delivery Market
Injectable/Implantable Delivery Technology Only Market
chapter five: Competitive and Market Analysis


Competitive Landscape
Market Analysis
Chapter six: Company Profiles


Alkermes, Inc.
ALZA Corp.
Antares Pharma, Inc.
Bioject Medical Technologies, Inc.
CyDex, Inc.
MGI Pharma, Inc
Nektar Therapeutics
PowderMed Pharmaceuticals Plc
SkyePharma Plc
Zogenix Corporation
Chapter seven: Companies in Brief


AP Pharma
Baxter BioPharma Solutions
ImaRx Therapeutics Inc.
PR Pharmaceuticals, Inc.
pSivida
QLT USA, Inc
Appendix: Company Directory



TABLE OF EXHIBITS



Chapter one: Executive Summary


Figure 1-1: The Worldwide Market for Injectable/Implantable
Drug Delivery Technology and Pharmaceuticals 2002-2010
Chapter two: Introduction


Table 2-1: Sequence of Drug Action
Chapter three: Trends and Developments


Table 3-1: Select Products in Early Stage Development by Drug
Delivery Companies
Chapter four: Market Size and Growth


Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2002-2010
Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2006
Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2010
Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
chapter five: Competitive and Market Analysis


Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
Figure 5-1: Cost per Million Injections by Injector Type
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems

Chapter one: Executive Summary


Market Drivers
Market Size and G